Literature DB >> 28887324

Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development.

Christine Dethlefsen1, Louise S Hansen1, Christian Lillelund2, Christina Andersen2, Julie Gehl3, Jesper F Christensen1, Bente K Pedersen1, Pernille Hojman4,3.   

Abstract

Strong epidemiologic evidence documents the protective effect of physical activity on breast cancer risk, recurrence, and mortality, but the underlying mechanisms remain to be identified. Using human exercise-conditioned serum for breast cancer cell incubation studies and murine exercise interventions, we aimed to identify exercise factors and signaling pathways involved in the exercise-dependent suppression of breast cancer. Exercise-conditioned serum from both women with breast cancer (n = 20) and healthy women (n = 7) decreased MCF-7 (hormone-sensitive) and MDA-MB-231 (hormone-insensitive) breast cancer cell viability in vitro by 11% to 19% and reduced tumorigenesis by 50% when preincubated MCF-7 breast cancer cells were inoculated into NMRI-Foxn1nu mice. This exercise-mediated suppression of cell viability and tumor formation was completely blunted by blockade of β-adrenergic signaling in MCF-7 cells, indicating that catecholamines were the responsible exercise factors. Both epinephrine (EPI) and norepinephrine (NE) could directly inhibit breast cancer cell viability, as well as tumor growth in vivo EPI and NE activate the tumor suppressor Hippo signaling pathway, and the suppressive effect of exercise-conditioned serum was found to be mediated through phosphorylation and cytoplasmic retention of YAP and reduced expression of downstream target genes, for example, ANKRD1 and CTGF. In parallel, tumor-bearing mice with access to running wheels showed reduced growth of MCF-7 (-36%, P < 0.05) and MDA-MB-231 (-66%, P < 0.01) tumors and, for the MCF-7 tumor, increased regulation of the Hippo signaling pathway. Taken together, our findings offer a mechanistic explanation for exercise-dependent suppression of breast cancer cell growth. Cancer Res; 77(18); 4894-904. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28887324     DOI: 10.1158/0008-5472.CAN-16-3125

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

Review 1.  β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.

Authors:  Xiao-Jun Du; Wei-Bo Zhao; My-Nhan Nguyen; Qun Lu; Helen Kiriazis
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 2.  Body composition and breast cancer risk and treatment: mechanisms and impact.

Authors:  Toshiaki Iwase; Xiaoping Wang; Tushaar Vishal Shrimanker; Mikhail G Kolonin; Naoto T Ueno
Journal:  Breast Cancer Res Treat       Date:  2021-01-21       Impact factor: 4.872

Review 3.  A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.

Authors:  Ainhoa Arana Echarri; Mark Beresford; John P Campbell; Robert H Jones; Rachel Butler; Kenneth J Gollob; Patricia C Brum; Dylan Thompson; James E Turner
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

Review 4.  Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?

Authors:  Niharika A Duggal; Grace Niemiro; Stephen D R Harridge; Richard J Simpson; Janet M Lord
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

Review 5.  Key steps for effective breast cancer prevention.

Authors:  Kara L Britt; Jack Cuzick; Kelly-Anne Phillips
Journal:  Nat Rev Cancer       Date:  2020-06-11       Impact factor: 60.716

Review 6.  Anti-carcinogenic effects of exercise-conditioned human serum: evidence, relevance and opportunities.

Authors:  Richard S Metcalfe; Rachael Kemp; Shane M Heffernan; Rachel Churm; Yung-Chih Chen; José S Ruffino; Gillian E Conway; Giusy Tornillo; Samuel T Orange
Journal:  Eur J Appl Physiol       Date:  2021-04-17       Impact factor: 3.078

Review 7.  Exercise-induced myokines and their effect on prostate cancer.

Authors:  Jin-Soo Kim; Daniel A Galvão; Robert U Newton; Elin Gray; Dennis R Taaffe
Journal:  Nat Rev Urol       Date:  2021-06-22       Impact factor: 14.432

Review 8.  Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer.

Authors:  Qinqin Li; Zhenghuan Rao; Yanlin Wang; Lei Zhang; Jing Chen; Runlan Wan; Alexander Tobias Teichmann
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

Review 9.  Using dynamic cell communication improves treatment strategies of breast cancer.

Authors:  Zhibo Liu; Song Hu; Zehui Yun; Wanshan Hu; Shuhua Zhang; Daya Luo
Journal:  Cancer Cell Int       Date:  2021-05-25       Impact factor: 5.722

10.  Loading-induced antitumor capability of murine and human urine.

Authors:  Di Wu; Yao Fan; Shengzhi Liu; Mark D Woollam; Xun Sun; Eiji Murao; Rongrong Zha; Rahul Prakash; Charles Park; Amanda P Siegel; Jing Liu; Mangilal Agarwal; Bai-Yan Li; Hiroki Yokota
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.